Cardioprotective effect of magnetic hydrogel nanocomposite loaded N,α-L-rhamnopyranosyl vincosamide isolated from Moringa oleifera leaves against doxorubicin-induced cardiac toxicity in rats : in vitro and in vivo studies
Cardioprotective effect of N, α-L-rhamnopyranosyl vincosamide (VR), isolated from the leaves of Moringa oleifera plant in doxorubicin (Dox)-induced cardiac toxicity rats was evaluated. Twelve (12) rats were randomly selected into three groups; two rats received distilled water in the control group, five rats in group I received varying concentration of VR treatment, and group II containing five rats received varying concentration of VR-loaded magnetic hydrogel nanocomposite. Malondialdehyde (MDA), glutathione peroxidase (GSH) and superoxide dismutase (SOD) enzymes activities level were analysed after two weeks. In addition, the expression of three heart failure markers; beta major histocompatibility complex (β-MHC), atrial natriuretic peptide (ANP), and B type natriuretic peptide (BNP) were also evaluated. It was observed that the level of these markers expression decreases with an increase in VR concentration (p < 0.05). The reduced GSH and SOD level were increased after VR administration, this extract also reduced the initially increased MDA level in cardiac tissue. Pharmacokinetic parameters evaluation showed that nanogel treated rats possesses a significantly increased VR plasma concentration, Cmax, Kel, t½(a), t½(el), Ka and AUC. The result of this study indicated that VR may help to lower the dosage level, and reduces the treatment course in cardiovascular diseases (CVD). Our conclusion proposes the cardio-protective ability of the isolated VR and its beneficial effect via free radical scavenging properties.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
Journal of microencapsulation - 34(2017), 4 vom: 25. Juni, Seite 335-341 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cheraghi, Mostafa [VerfasserIn] |
---|
Links: |
---|
Themen: |
80168379AG |
---|
Anmerkungen: |
Date Completed 18.12.2017 Date Revised 02.12.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/02652048.2017.1311955 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM270933239 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM270933239 | ||
003 | DE-627 | ||
005 | 20231224231625.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/02652048.2017.1311955 |2 doi | |
028 | 5 | 2 | |a pubmed24n0903.xml |
035 | |a (DE-627)NLM270933239 | ||
035 | |a (NLM)28406043 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cheraghi, Mostafa |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cardioprotective effect of magnetic hydrogel nanocomposite loaded N,α-L-rhamnopyranosyl vincosamide isolated from Moringa oleifera leaves against doxorubicin-induced cardiac toxicity in rats |b in vitro and in vivo studies |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.12.2017 | ||
500 | |a Date Revised 02.12.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Cardioprotective effect of N, α-L-rhamnopyranosyl vincosamide (VR), isolated from the leaves of Moringa oleifera plant in doxorubicin (Dox)-induced cardiac toxicity rats was evaluated. Twelve (12) rats were randomly selected into three groups; two rats received distilled water in the control group, five rats in group I received varying concentration of VR treatment, and group II containing five rats received varying concentration of VR-loaded magnetic hydrogel nanocomposite. Malondialdehyde (MDA), glutathione peroxidase (GSH) and superoxide dismutase (SOD) enzymes activities level were analysed after two weeks. In addition, the expression of three heart failure markers; beta major histocompatibility complex (β-MHC), atrial natriuretic peptide (ANP), and B type natriuretic peptide (BNP) were also evaluated. It was observed that the level of these markers expression decreases with an increase in VR concentration (p < 0.05). The reduced GSH and SOD level were increased after VR administration, this extract also reduced the initially increased MDA level in cardiac tissue. Pharmacokinetic parameters evaluation showed that nanogel treated rats possesses a significantly increased VR plasma concentration, Cmax, Kel, t½(a), t½(el), Ka and AUC. The result of this study indicated that VR may help to lower the dosage level, and reduces the treatment course in cardiovascular diseases (CVD). Our conclusion proposes the cardio-protective ability of the isolated VR and its beneficial effect via free radical scavenging properties | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cardioprotective | |
650 | 4 | |a Moringa oleifera | |
650 | 4 | |a cardiac toxicity | |
650 | 4 | |a doxorubicin | |
650 | 4 | |a pharmacokinetics | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a Cardiotonic Agents |2 NLM | |
650 | 7 | |a Hydrogels |2 NLM | |
650 | 7 | |a Indole Alkaloids |2 NLM | |
650 | 7 | |a Magnetite Nanoparticles |2 NLM | |
650 | 7 | |a vincosamide |2 NLM | |
650 | 7 | |a Doxorubicin |2 NLM | |
650 | 7 | |a 80168379AG |2 NLM | |
700 | 1 | |a Namdari, Mehrdad |e verfasserin |4 aut | |
700 | 1 | |a Daraee, Hadis |e verfasserin |4 aut | |
700 | 1 | |a Negahdari, Babak |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of microencapsulation |d 1989 |g 34(2017), 4 vom: 25. Juni, Seite 335-341 |w (DE-627)NLM013098217 |x 1464-5246 |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2017 |g number:4 |g day:25 |g month:06 |g pages:335-341 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/02652048.2017.1311955 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 34 |j 2017 |e 4 |b 25 |c 06 |h 335-341 |